Quantbot Technologies LP cut its stake in The Clorox Company (NYSE:CLX – Free Report) by 98.0% in the third quarter, Holdings Channel reports. The fund owned 272 shares of the company’s stock after selling 13,188 shares during the period. Quantbot Technologies LP’s holdings in Clorox were worth $44,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of CLX. Insight Folios Inc increased its position in Clorox by 3.0% during the third quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after purchasing an additional 63 shares during the last quarter. Fiduciary Group LLC grew its stake in shares of Clorox by 0.4% in the 2nd quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock valued at $2,600,000 after buying an additional 72 shares during the period. GHP Investment Advisors Inc. increased its holdings in shares of Clorox by 2.0% during the 2nd quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock worth $496,000 after buying an additional 72 shares during the last quarter. SPC Financial Inc. raised its position in shares of Clorox by 2.2% during the 2nd quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock valued at $476,000 after buying an additional 75 shares during the period. Finally, Massmutual Trust Co. FSB ADV grew its position in Clorox by 17.2% in the third quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock worth $83,000 after acquiring an additional 75 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Analysts Set New Price Targets
CLX has been the topic of a number of research analyst reports. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and lifted their target price for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Evercore ISI decreased their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. Barclays lifted their price target on shares of Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research report on Friday, November 1st. JPMorgan Chase & Co. upped their price objective on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Finally, TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and lifted their target price for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Five analysts have rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $155.00.
Clorox Stock Down 1.6 %
Shares of NYSE CLX opened at $166.97 on Friday. The stock has a market cap of $20.67 billion, a P/E ratio of 58.18, a PEG ratio of 3.10 and a beta of 0.42. The business’s fifty day simple moving average is $163.50 and its 200-day simple moving average is $150.49. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the company earned $0.49 EPS. Clorox’s revenue for the quarter was up 27.0% compared to the same quarter last year. As a group, equities analysts predict that The Clorox Company will post 6.85 EPS for the current fiscal year.
Clorox Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 2.92%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 170.04%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- Upcoming IPO Stock Lockup Period, Explained
- Fast-Growing Companies That Are Still Undervalued
- How to trade using analyst ratings
- Top Cybersecurity Stock Picks for 2025
- The 3 Best Blue-Chip Stocks to Buy Now
- Archer or Joby: Which Aviation Company Might Rise Fastest?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.